Author Correction: Safety and efficacy of anti-tau monoclonal antibody gosuranemab in progressive supranuclear palsy: a phase 2, randomized, placebo-controlled trial (Nature Medicine, (2021), 27, 8, (1451-1457), 10.1038/s41591-021-01455-x)

PASSPORT Study Group

Research output: Contribution to journalComment/debatepeer-review

Abstract

Correction to: Nature Medicine, published online 12 August 2021. In the version of this article initially published, members of the PASSPORT Study Group were listed in Supplementary information but not included in the main article. The contributors are listed below for inclusion in authorship. PASSPORT Study Group Ikuko Aiba1, Angelo Antonini2, Diana Apetauerova3, Jean-Philippe Azulay4, Ernest Balaguer Martinez5, Jee Bang6, Paolo Barone7, Matthew Barrett8, Danny Bega9, Daniela Berg10, Koldo Berganzo Corrales11, Yvette Bordelon12, Adam L. Boxer13, Moritz Brandt14, Norbert Brueggemann15, Giovanni Castelnovo16, Roberto Ceravolo17, Rosalind Chuang18, Sun Ju Chung19, Alistair Church20, Jean-Christophe Corvol21, Paola Cudia2, Marian Dale22, Luc Defebvre23, Sophie Drapier24, Erika D Driver-Dunckley25, Georg Ebersbach26, Karla M Eggert27, Aaron Ellenbogen28, Alexandre Eusebio4, Andrew H Evans29, Natalia Fedorova30, Elizabeth Finger31, Alexandra Foubert-Samier32, Boyd Ghosh33, Lawrence Golbe34, Francisco Grandas Perez35, Murray Grossman36, Deborah Hall37, Kyoko Hamada38, Kazuko Hasegawa39, Guenter Hoeglinger40, Lawrence Honig41, David Houghton42, Xuemei Huang43, Stuart Isaacson44, SeongBeom Koh45, Jaime Kulisevsky Bojarski46, Anthony E. Lang47, Peter Nigel Leigh48, Irene Litvan49, Juan Jose Lopez Lozano50, Jose Luis Lopez-Sendon Moreno51, Albert Christian Ludolph52, Ma Rosario Luquin Piudo53, Irene Martinez Torres54, Nikolaus McFarland55, Wassilios Meissner32, Tiago Mestre56, Pablo Mir Rivera57, Eric Molho58, Britt Mollenhauer59, Huw R Morris60, Miho Murata61, Tomokazu Obi62, Fabienne Ory Magne63, Padraig O’Suilleabhain64, Rajesh Pahwa65, Alexander Pantelyat6, Nicola Pavese66, Dmitry Pokhabov67, Johannes Prudlo68, Federico Rodriguez-Porcel22, James Rowe69, Joseph Savitt70, Alfons Schnitzler71, Joerg B Schulz72, Klaus Seppi73, Binit Shah8, Holly Shill74, David Shprecher75, Maria Stamelou76, Malcolm Steiger77, Yuji Takahashi61, Hiroshi Takigawa78, Carmela Tartaglia79, Lars Toenges80, Daniel Truong81, Winona Tse82, Paul Tuite83, Dieter Volc84, Anne-Marie A Wills85, Dirk Woitalla86, Tao Xie87, Tatsuhiko Yuasa88, Sarah Elizabeth Zauber89 and Theresa Zesiewicz90 1Department of Neurology, National Hospital Organization Higashinagoya National Hospital, Nagoya, Japan. 2San Camillo Hospital IRCCS, Venice Lido, Italy. 3Lahey Hospital and Medical Center, Burlington, MA, USA. 4Assistance Publique Hapitaux De Marseille, Marseille, France. 5Hospital General de Catalunya, Barcelona, Spain. 6The Johns Hopkins University, Baltimore, MD, USA. 7AOU San Giovanni di Dio e Ruggi d’Aragona University di Salerno, Salerno, Italy. 8University of Virginia Health System, Charlottesville, VA, USA. 9Northwestern University, Chicago, IL, USA. 10UKSH - Campus Kiel, Kiel, Germany. 11Hospital De Cruces, Barakaldo, Spain. 12University of California, Los Angeles, CA, USA. 13Memory and Aging Center, Department of Neurology, University of California, San Francisco, CA, USA. 14Universitatsklinikum Carl Gustav Carus Dresden, Dresden, Germany. 15University Hospital Schleswig-Holstein, Luebeck, Germany. 16Centre Hospitalier Universitaire de Nimes - Hopital Universitaire Caremeau, Nimes, France. 17University Hospital of Pisa, Pisa, Italy. 18Swedish Health Services, Seattle, WA, USA. 19Asan Medical Center, Seoul, Republic of Korea. 20Aneurin Bevan University Health BoardClinical Research and Innovation Centre - St Woolos Hospital, Newport, UK. 21Sorbonne Université, Assistance Publique Hôpitaux de Paris, INSERM, CNRS, Institut du Cerveau – Paris Brain Institute – ICM, Hôpital Pitié-Salpêtrière, Paris, France. 22Medical University of South Carolina, Charleston, SC, USA. 23Centre Hospitalier Regional Universitaire) de Lille - Hopital Roger Salengro, Lille, France. 24CHU de Rennes - Hopital de Pontchaillou, Rennes, France. 25Mayo Clinic Arizona - Scottsdale, Scottsdale, AZ, USA. 26Movement Disorders Clinic, Beelitz-Heilstatten, Germany. 27Philipps Universitat Marburg, Marburg, Germany. 28QUEST Research Institute, Farmington Hills, MI, USA. 29The Royal Melbourne Hospital (RMH)-Flemington Neurology - North Melbourne, North Melbourne, Australia. 30Russian Medical Academy of Postgraduate Education, Moscow, Russia. 31Parkwood Institute, London, Ontario, Canada. 32CHU De Bordeaux Parkinson Expert Centre, IMNC Hopital Pellegrin, Bordeaux, France. 33University Hospital Southampton NHS Foundation Trust, Southampton UK. 34 Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ, USA. 35Hospital General Universitario Gregorio Maranon, Madrid, Spain. 36Hospital of the University of Pennsylvania, Philadelphia, PA, USA. 37Rush University Medical Centre Chicago, IL USA. 38Shinsapporo Neurosurgical Hospital, Sapporo, Japan. 39National Hospital Organization Sagamihara National Hospital, Sagamihara, Japan. 40Department of Neurology, Technische Universität München, Munich, Germany. 41Columbia University College of Physicians and Surgeons - Gertrude H. Sergievsky Center, New York, NY, USA. 42Ochsner Medical Center, New Orleans, LA, USA. 43Penn State University-Milton S. Hershey Medical Center, Hershey, PA USA. 44Parkinson’s Disease And Movement Disorder Center Of Boca Raton, Boca Raton, FL, USA. 45Korea University Guro Hospital, Seoul, Republic of Korea. 46Hospital de la Santa Creu i Sant Pau, Barcelona, Spain. 47 Edmond J. Safra Program in Parkinson’s Disease and the Rossy PSP Centre, Toronto Western Hospital and the University of Toronto, Toronto, Ontario, Canada. 48Brighton and Sussex Medical School Trafford Centre for Biomedical Research, Brighton, UK. 49University of California, Parkinson and Other Movement Disorders Center, San Diego, CA, USA. 50Clinica Ruber Internacional, Madrid, Spain. 51Hospital Universitario Ramon y Cajal, Madrid, Spain. 52Universitats- und Rehabilitationskliniken Ulm, Ulm, Germany. 53Clinica Universidad De Navarra, Pamplona, Spain. 54Hospital la FE, Valencia, Spain. 55University of Florida Center For Movement Disorders and Neurorestoration, Gainesville, FL, USA. 56The Ottawa Hospital - Civic Campus, University of Ottawa, Ottawa, Canada. 57Hospital Universitario Virgen del Rocio, Sevilla, Spain. 58Albany Medical College, Albany, NY, USA. 59Paracelsus-Elena-Klinik Kassel, Kassel, Germany. 60National Hospital for Neurology and Neurosurgery, London, UK. 61Musashi Hospital, Kodaira-Shi, Japan. 62National Hospital Organization - Shizuoka Institute of Epilepsy and Neurological Disorders, Shizuoka, Japan. 63Hopital Purpan - Batiment Pierre Paul Riquet, Toulouse, France. 64University of Texas Southwestern Medical Center - Clinical Center For Movement Disorders, Dallas, TX, USA. 65The University of Kansas Medical Center - Parkinson’s Disease and Movement Disorder Center, Kansas City, KS, USA. 66The Newcastle upon Tyne Hospitals NHS Foundation Trust - Campus for Ageing and Vitality, Newcastle upon Tyne, UK. 67Federal State Budgetary Institution, Federal Siberian Scientific Clinical Center of Federal Medical-Biological Agency, Krasnoyarsk, Russia. 68Universitaet Rostock - Universitaetsmedizin Rostock, Rostock, Germany. 69Cambridge University, Cambridge, UK. 70University of Maryland School of Medicine, Baltimore, MD, USA. 71Center for Movement Disorders and Neuromodulation-University Hospital Dusseldorf, Dusseldorf, Germany. 72Uniklinik RWTH Aachen Medizinische Klinik III, Aachen, Germany. 73Medizinische Universitaet Innsbruck, Innsbruck, Austria. 74St. Joseph’s Hospital and Medical Center/Barrow Neurology Clinics, Phoenix, AZ, USA. 75Banner Sun Health Research Institute, Sun City, AZ, USA. 76Hygeia Hospital, Marousi, Greece. 77The Walton Center - NHS Foundation Trust, Liverpool, UK. 78Tottori University Hospital, Yonago, Japan. 79Toronto Western Hospital, University Health Network Movement Disorders Centre, Toronto, Canada. 80St. Josef - Hospital Bochum, Kardiologische Studienambulanz, Bochum, Germany. 81The Parkinson’s and Movement Disorder Institute, Fountain Valley, CA, USA. 82Mount Sinai Movement Disorders Center, New York,NY, USA. 83University of Minnesota Medical Center - Fairview - Neurology Clinic, Minneapolis, MN, USA. 84Prosenex Ambulatoriumsbetriebs GmbH – Studienzentrum, Vienna, Austria. 85Massachusetts General Hospital Cancer Center, Boston, MA, USA. 86St. JosefKrankenhaus, Essen-Kupferdreh, Essen, Germany. 87The University of Chicago Medicine - Center for Parkinson’s Disease and Movement Disorders, Chicago, IL, USA. 88Kamagaya General Hospital, Kamagaya-City, Japan. 89Indiana University Health Physicians - Neurology – Indianapolis, Indianapolis, IN, USA. 90University of South Florida - Morsani College of Medicine, Tampa, FL, USA.

Original languageEnglish (US)
Pages (from-to)2955-2956
Number of pages2
JournalNature Medicine
Volume29
Issue number11
DOIs
StatePublished - Nov 2023

ASJC Scopus subject areas

  • General Biochemistry, Genetics and Molecular Biology

Fingerprint

Dive into the research topics of 'Author Correction: Safety and efficacy of anti-tau monoclonal antibody gosuranemab in progressive supranuclear palsy: a phase 2, randomized, placebo-controlled trial (Nature Medicine, (2021), 27, 8, (1451-1457), 10.1038/s41591-021-01455-x)'. Together they form a unique fingerprint.

Cite this